Caris Life Sciences, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 216.2M | 292.9M | 216.8M | 181.4M | 120.9M | 100.0M | 80.7M | 100.8M |
| Cost of Goods Sold | 74.8M | 72.0M | 69.3M | 67.7M | 63.9M | 62.5M | 54.6M | 46.7M |
| Gross Profit | 141.3M | 220.9M | 147.5M | 113.7M | 57.1M | 37.6M | 26.1M | 54.1M |
| R&D Expenses | 5.4M | 31.8M | 21.6M | 25.0M | 23.1M | 24.8M | 34.4M | 0 |
| Operating Expenses | 136.1M | 132.5M | 114.9M | 95.7M | 115.0M | -29.5M | 118.3M | 12.3M |
| Operating Income | 5.3M | 88.4M | 32.6M | 18.0M | -58.0M | 67.0M | -92.2M | 66.4M |
| Other Income / Gains | -5.9M | -6.5M | -8.3M | -89.8M | -44.6M | -133.2M | -18.8M | -11.6M |
| Net Income | -510K | 82.0M | 24.3M | -71.8M | -102.6M | -66.2M | -111.0M | 51.2M |
| EPS (Diluted) | -0.002 | 0.29 | 0.086 | -1.93 | -0.40 | -0.35 | -0.53 | 2.95 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.654 | 0.754 | 0.68 | 0.627 | 0.472 | 0.375 | 0.324 | 0.536 |
| General And Administrative Expenses | 59.7M | 56.5M | 52.0M | 64.4M | 53.4M | 41.1M | 45.5M | 12.3M |
| Selling And Marketing Expenses | 45.0M | 44.2M | 41.3M | 42.3M | 38.6M | 38.7M | 38.5M | 0 |
| Selling General And Administrative Expenses | 104.8M | 100.7M | 93.2M | 106.6M | 91.9M | 79.8M | 84.0M | 12.3M |
| Other Expenses | 25.9M | 0 | 0 | -36.0M | 1K | -134.0M | 0 | 0 |
| Cost And Expenses | 210.9M | 204.5M | 184.2M | 163.4M | 178.9M | 33.0M | 172.9M | 59.0M |
| Interest Income | 6.8M | 7.0M | 7.4M | 1.6M | 503K | 2.6M | 1.8M | 0 |
| Interest Expense | 12.8M | 11.4M | 13.5M | 19.2M | 12.8M | 13.7M | 9.3M | 0 |
| Depreciation And Amortization | 5.1M | 4.3M | 4.9M | 6.4M | 7.0M | 11.6M | 17.7M | 32.9M |
| Ebitda | 10.3M | 97.6M | 42.7M | -46.2M | -82.8M | -40.9M | -84.0M | 87.7M |
| Ebitdaratio | 0.048 | 0.333 | 0.197 | -0.255 | -0.684 | -0.409 | -1.042 | 0.87 |
| Operating Income Ratio | 0.024 | 0.302 | 0.151 | 0.099 | -0.479 | 0.67 | -1.143 | 0.659 |
| Income Before Tax | -644K | 82.0M | 24.3M | -71.8M | -102.6M | -66.2M | -111.0M | 54.8M |
| Income Before Tax Ratio | -0.003 | 0.28 | 0.112 | -0.396 | -0.848 | -0.662 | -1.376 | 0.544 |
| Income Tax Expense | -134K | 0 | 0 | 0 | 0 | 0 | 0 | 3.7M |
| Net Income Ratio | -0.002 | 0.28 | 0.112 | -0.396 | -0.848 | -0.662 | -1.376 | 0.507 |
| Epsdiluted | -0.002 | 0.28 | 0.082 | -1.87 | -0.40 | -0.35 | -0.53 | 2.92 |
| Weighted Average Shs Out | 282.6M | 1.67B | 282.1M | 268.4M | 254.8M | 254.8M | 254.8M | 17.3M |
| Weighted Average Shs Out Dil | 282.6M | 1.67B | 297.2M | 276.0M | 254.8M | 254.8M | 254.8M | 17.5M |